Skip to main content
. 2022 Dec 14;4(12):e0819. doi: 10.1097/CCE.0000000000000819

TABLE 1.

Features of the Participants

Feature At-Risk for PARDS, N = 35 Nonsevere PARDS, N = 34 Severe PARDS, N = 13
Age, mo 10 (3–28) 11 (3–21) 23 (4–28)
Male 20 (57.1) 20 (58.8) 8 (61.5)
Ethnicity
 Hispanic/Latino 2 (5.7) 0 1 (7.7)
 Not Hispanic/Latino 32 (91.4) 34 (100) 12 (92.3)
 Unknown/not reported 1 (2.9) 0 0
Race
 White or White-Hispanic 13 (37.1) 10 (29.4) 4 (30.8)
 Black or Black-Hispanic 20 (57.1) 22 (64.7) 6 (46.2)
 Multiple races 0 2 (5.9) 3 (23.1)
 Other 1 (2.9) 0 0
 Unknown/not reported 1 (2.9) 0 0
Pediatric Risk of Mortality-III score 12 (8–17) 14 (9–17) 16 (12–20)
Pediatric Logistic Organ Dysfunction score 5 (4–8) 6 (5–6) 9 (5–12)a,b
Viral respiratory culture
 Not performed 7 (20.0) 5 (14.7) 0
 No virus 3 (8.6) 4 (11.8) 3 (23.1)
 Positive virus 21 (60.0) 21 (61.8) 8 (61.5)
 Positive multiple virus 4 (11.4) 4 (11.8) 2 (15.4)
Bacterial respiratory culture
 Not performed 17 (48.6) 4 (11.8) 3 (23.1)
 No bacteria 1 (2.9) 2 (5.9) 0
 Positive bacteria or yeast 17 (48.6) 28 (82.4)a 10 (76.9)a
Hours to sample collection 17 (12–22) 21 (11–37) 23 (11–43)
Hospital days 10 (7–13) 16 (7–19) 21 (15–38)a,b
PICU days 7 (4–10) 8 (6–13) 15 (10–32)a,b
Ventilator days 4 (2–6) 5 (3–8)a 7 (6–20)a,b
28-d ventilator-free days 25 (22–26) 23 (19–24)a 19 (5–22)a,b
Extracorporeal membranous oxygenation 0 1 (2.9) 5 (38.5)a,b
Died 1 (2.9) 1 (2.9) 1 (7.7)

PARDS = pediatric acute respiratory distress syndrome.

a

p < 0.05 vs at-risk.

b

p < 0.05 vs nonsevere.

Data are shown as the median (25–75th percentile) or the number of participants (n) (%).